Ann Lab Med.  2017 Nov;37(6):556-558. 10.3343/alm.2017.37.6.556.

First Case of Echinocandin-Resistant Candida albicans in Korea

• Park MS
• Park JE
• Song DJ
• Huh HJ
• Park S
• Kang CI
• Shin JH
• Lee NY

• KMID: 2426003
• DOI: http://doi.org/10.3343/alm.2017.37.6.556

Abstract

No abstract available.

MeSH Terms

Candida albicans*
Candida*
Korea*

Reference

1. Alexander BD, Johnson MD, Pfeiffer CD, Jiménez-Ortigosa C, Catania J, Booker R, et al. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis. 2013; 56:1724–1732. PMID: 23487382.

2. Castanheira M, Messer SA, Rhomberg PR, Pfaller MA. Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013). Diagn Microbiol Infect Dis. 2016; 85:200–204. PMID: 27061369.

3. Jang MJ, Shin JH, Lee WG, Kim MN, Lee K, Lee HS, et al. In vitro fluconazole and voriconazole susceptibilities of Candida bloodstream isolates in Korea: use of the CLSI and EUCAST epidemiological cutoff values. Ann Lab Med. 2013; 33:167–173. PMID: 23667842.

4. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved Standard. CLSI document M27-A3. Wayne, PA: Clinical and Laboratory Standards Institute 2008a;2008. 28:p. 6–12.

5. Slater JL, Howard SJ, Sharp A, Goodwin J, Gregson LM, Alastruey-Izquierdo A, et al. Disseminated Candidiasis caused by Candida albicans with amino acid substitutions in Fks1 at position Ser645 cannot be successfully treated with micafungin. Antimicrob Agents Chemother. 2011; 55:3075–3083. PMID: 21502627.

6. Shields RK, Nguyen MH, Press EG, Cumbie R, Driscoll E, Pasculle AW, et al. Rate of FKS mutations among consecutive Candida isolates causing bloodstream infection. Antimicrob Agents Chemother. 2015; 59:7465–7470. PMID: 26392494.

7. Cho EJ, Shin JH, Kim SH, Kim HK, Park JS, Sung H, et al. Emergence of multiple resistance profiles involving azoles, echinocandins and amphotericin B in Candida glabrata isolates from a neutropenia patient with prolonged fungaemia. J Antimicrob Chemother. 2015; 70:1268–1270. PMID: 25550394.

8. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, et al. Guidelines for treatment of candidiasis. Clin Infect Dis. 2004; 38:161–189. PMID: 14699449.

9. Maertens J, Marchetti O, Herbrecht R, Cornely OA, Flückiger U, Frêre P, et al. European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update. Bone Marrow Transplant. 2011; 46:709–718. PMID: 20661235.

10. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; Fourth Informational Supplement. CLSI document M27-S4. Wayne, PA: Clinical and Laboratory Standards Institute;2012.